Niva Bupa Health Insurance Company

71.70
+0.63
(0.89%)
Market Cap
13,099.78 Cr
EPS
0.51
PE Ratio
79.02
Dividend Yield
0.00 %
Industry
0.00
52 Week High
109.34
52 Week low
69.21
PB Ratio
4.54
Debt to Equity
0.17
Sector
0.00
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy0.0 %
0.0 %
Hold100.00 %
100.00 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
No data
Growth Rate
Revenue Growth
34.36 %
Net Income Growth
555.20 %
Cash Flow Change
37.13 %
ROE
302.94 %
ROCE
604.35 %
EBITDA Margin (Avg.)
384.62 %

Yearly Financial Results

Annual Financials
2022
2023
2024
TTM
Revenue
2,159
3,227
4,336
5,269
Expenses
2,355
3,215
4,254
5,105
EBITDA
-197
13
82
165
Operating Profit %
-11 %
-2 %
-1 %
-12 %
Depreciation
0
0
0
0
Interest
0
0
0
0
Profit Before Tax
-197
13
82
165
Tax
0
0
0
0
Net Profit
-197
13
82
165
EPS in ₹
-1.42
0.09
0.51
1.00

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
-271
64
1,369
Fixed Assets
49
52
58
Current Assets
287
455
675
Capital Work in Progress
1
4
1
Investments
2,401
3,366
5,458
Other Assets
-2,722
-3,357
-4,148
Total Liabilities
858
1,180
2,394
Current Liabilities
1,983
2,799
3,891
Non Current Liabilities
250
250
250
Total Equity
1,532
1,842
2,983
Reserve & Surplus
125
334
1,282
Share Capital
1,409
1,511
1,700

Cash Flow

Cash Flow
2017
2021
2022
2023
2024
Net Cash Flow
4
164
-12
43
41
Investing Activities
-32
-374
-723
-829
-1,882
Operating Activities
8
257
338
593
813
Financing Activities
28
281
374
280
1,110

Share Holding

% Holding
Jun 2024
Nov 2024
Dec 2024
Promoter
62.94 %
55.98 %
55.98 %
FIIs
0.00 %
8.63 %
8.85 %
DIIs
0.00 %
9.57 %
9.83 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
4.71 %
4.43 %
Others
37.06 %
21.12 %
20.92 %
No of Share Holders
86
1,60,440
1,46,255

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
9 days ago
Announcement under Regulation 30 (LODR)-Acquisition
Feb 28, 2025, 17:27
Announcement under Regulation 30 (LODR)-Acquisition
Feb 28, 2025, 17:27
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 25, 2025, 14:03
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 25, 2025, 14:03
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Feb 24, 2025, 15:00
Reporting Cyber Threat
Feb 21, 2025, 16:29
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Feb 13, 2025, 13:24
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 12, 2025, 18:00
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 10, 2025, 13:06
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 06, 2025, 14:49
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Feb 05, 2025, 18:18
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 04, 2025, 22:10
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 04, 2025, 20:16
Integrated Filing (Financial)
Feb 04, 2025, 18:19
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 04, 2025, 17:32
Re-Appointment Of Mr. Krishnan Ramachandran As Managing Director & CEO Of The Company.
Feb 04, 2025, 17:24
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024
Feb 04, 2025, 17:13
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 31, 2025, 13:02
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 29, 2025, 16:48
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 29, 2025, 16:22
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter Ended December 31 2024.
Jan 29, 2025, 16:18
Announcement under Regulation 30 (LODR)-Cessation
Jan 20, 2025, 11:30
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Jan 17, 2025, 17:47
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Jan 17, 2025, 17:42
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 13, 2025, 11:43
Closure of Trading Window
Dec 30, 2024, 13:12
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dec 17, 2024, 13:48
General Update
Dec 16, 2024, 18:04
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Dec 16, 2024, 16:58
Announcement under Regulation 30 (LODR)-Change in Management
Dec 14, 2024, 24:02
Announcement under Regulation 30 (LODR)-Cessation
Dec 10, 2024, 14:19
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 10, 2024, 14:10
Rumour verification - Regulation 30(11)
Dec 03, 2024, 16:41
Clarification sought from Niva Bupa Health Insurance Company Ltd
Dec 03, 2024, 14:30
Reporting Cyber Threat
Nov 29, 2024, 17:30
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 29, 2024, 14:38
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 27, 2024, 17:30
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 25, 2024, 18:53
Announcement under Regulation 30 (LODR)-Investor Presentation
Nov 25, 2024, 16:09
Un-Audited Financial Results For Quarter And Half Year Ended September, 2024
Nov 25, 2024, 14:48
Board Meeting Outcome for Outcome Of Board Meeting Held On November 25, 2024- Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024.
Nov 25, 2024, 14:30
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 20, 2024, 18:02
Board Meeting Intimation for Intimation Of Board Meeting For Approval Of Financial Results
Nov 20, 2024, 17:58
Disclosure Under Regulation 30(5) Of The SEBI (LODR) Regulations, 2015
Nov 14, 2024, 13:06
Intimation Pursuant To Regulation 8(1) And 8(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
Nov 14, 2024, 13:00
Closure of Trading Window
Nov 14, 2024, 12:56

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
37.56
ATR(14)
Less Volatile
2.98
STOCH(9,6)
Neutral
22.69
STOCH RSI(14)
Neutral
33.72
MACD(12,26)
Bearish
-0.40
ADX(14)
Weak Trend
17.63
UO(9)
Bearish
40.59
ROC(12)
Downtrend And Accelerating
-5.34
WillR(14)
Oversold
-87.53